**Date:** October 24, 2007

**From:** Scientific Program Committee, 57th Annual EIS Conference\
Eric Mintz, MD, MPH, National Center for Zoonotic, Vector-Borne, and
Enteric Diseases, Scientific Program Committee Chair\
Bruce Bernard, MD, MPH, National Institute for Occupational Safety and
Health, Scientific Program Committee Co-Chair

## **Subject:** **Call for Abstracts --- Epidemic Intelligence Service (EIS) Conference, April 14--18, 2008**

**To:** EIS Officers and Alumni

**The 57th Annual EIS Conference will be held April 14**--**18, 2008.
The site of this year's Conference will be announced in early January
2008.**

The Conference primarily highlights epidemiological contributions of
current EIS officers. EIS alumni may also submit abstracts for
consideration by the Scientific Program Committee. In reviewing
abstracts, the Scientific Program Committee will consider both abstract
quality and program balance. For this year\'s program, two presentation
categories are being considered: oral and poster. Each category will
consist of excellent abstracts on a variety of topics.

# Submission of Abstracts and Continuing Medical Education (CME) Documents

**Deadline for Submission.** Edited and cleared abstracts and supporting
documentation must be received by Friday, January 11, 2008. Abstracts
received after this date will not be considered.

**NOTE:** CIOs will set their own (earlier) deadline for abstracts to be
submitted for clearance within the CIO.

**Preparation.** Included in the "Call for Abstracts" are the attached
document, "2008 Call for Abstracts.doc," procedures for submitting an
abstract, technical instructions for abstract preparation, and a sample
abstract. These documents will also be available online after November
9, 2007 at <http://www.cdc.gov/eis/conference/conference.htm>

**Transmission.** Abstracts and supporting documentation should be
submitted as email attachments (in Microsoft Word) to:
<EISConfAbstracts@cdc.gov>

**NOTE:** Abstracts also will be accepted on a 3.5" floppy diskette, 700
mb/ 80 Min CD-R, or a flash drive sent to Ms. Dorothy Jones, EIS Program
Office, 1600 Clifton Road, MS E-92, Atlanta, GA 30333. Abstracts
submitted on diskette, CD, or flashdrive must be received by Friday,
January 11, 2008.

**Evaluation.** The Scientific Program Committee will use the EIS
Conference Abstract Evaluation Form when reviewing each abstract. Your
abstract should address each of the six components listed on the form. A
copy of this form is included in this document.

**Continuing Medical Education (CME).** To meet the requirements for
offering continuing education at the conference, we ask that you
complete the required forms at time of abstract submission. When
submitting your abstracts, also attach a completed: Biographical Data
Form and Conflict of Interest Disclosure Form for each abstract.

**Acceptance/Rejection Notification.** EIS Officers and alumni who
submit abstracts will be sent notifications by February 15, 2008.
Acceptance letters will indicate the type of presentation to prepare
(oral or poster). If the Scientific Program Committee determines an
abstract needs to be rewritten, the abstract will be returned before
being accepted.

# DONALD C. MACKEL MEMORIAL AWARD

The EIS Alumni Association will sponsor the 23rd Donald C. Mackel
Memorial Award, to be presented during the Conference. This award
recognizes the presentation that best exemplifies the effective
application of a combined epidemiological and laboratory approach to an
investigation. Presentations for which the first author is a current EIS
Officer and at least one coauthor is a laboratorian (CDC, state health
department, or other) may be considered for the award. The Mackel
Committee will NOT consider any abstract for the Mackel Award if
laboratory results are not included in the abstract.

The Donald C. Mackel Memorial Award Committee, co-chaired by
representatives from the Coordinating Center for Infectious Diseases and
the National Center for Environmental Health, will be responsible for
selecting the year 2008 winners. 

Instructions on how to notify the Scientific Program Committee of your
interest to be considered for the Mackel Award and instructions for
nominating your abstract for consideration for the Mackel Award are
included at the end of the document.

# J. VIRGIL PEAVY MEMORIAL AWARD

The EIS Alumni Association will sponsor the 6th J. Virgil Peavy Memorial
Award, to be presented during the Conference. This award recognizes the
presentation that best exemplifies the effective application of
statistical methods to an investigation. The J. Virgil Peavy Memorial
Award Committee will be responsible for selecting the 2008 winner. The
Peavy Committee will not consider any abstract for the Peavy Award if
statistical methods are not clearly described in the abstract.

If you wish to be considered for the Peavy Award, please indicate your
interest in the identification block of the abstract. Instructions for
nominating your abstract for consideration for the Peavy Award may be
found in the Peavy Award instructions at the end of the document.

# INTERNATIONAL NIGHT

The International Night session, sponsored by the Office of Global
Health, Office of Workforce and Career Development (OWCD), and the
Training Programs in Epidemiology and Public Health Interventions
Network (TEPHINET), has been a regular evening feature of the EIS
Conference. International Night provides an opportunity for
presentations by EIS officers and trainees from Field Epidemiology
Training Programs around the world.

This year, the Scientific Program Committee, in collaboration with
Office of Global Health and TEPHINET, is offering EIS officers an
opportunity to present during the International Night session and
receive credit for presentation at the EIS Conference. If you are
willing to present at International Night, please indicate your interest
in the identification block of the abstract.

# MORE INFORMATION

If you have any questions, please contact Dorothy Jones at 404-498-6110
(phone) or 404-498-6535 (fax). The Call for Abstract documents may also
be found on the EIS website at
<http://www.cdc.gov/eis/conference/conference.htm>.

We are looking forward to the 57th Annual EIS Conference, April 14--18,
2008, and hope to see you there!

# Number range CHAPTERABSTRACT INSTRUCTIONS

## Procedures and Deadline

-   Cleared and edited abstracts must be RECEIVED in the EIS Program
    Office by January 11, 2008. Abstracts should be submitted as email
    attachments and sent to: <EISConfAbstracts@cdc.gov>.

-   Your CIO\'s deadline will be earlier than this date to allow time
    for Center clearance. Please consult your CIO Editorial Office for
    their submission date.

-   If you do not have access to electronic mail, send the abstract and
    supporting documents as Word documents on a 3.5" floppy diskette,
    700 mb/ 80 Min CD-R, or a flash drive, along with a printed copy to:

> Dorothy Jones (<eaq6@cdc.gov>)
>
> 2008 EIS Conference Coordinator
>
> Office of Workforce and Career Development
>
> Centers for Disease Control and Prevention
>
> 1600 Clifton Road, NE, MS E-92
>
> Atlanta, GA 30333

-   If you have questions, please contact Ms. Jones at 404-498-6110
    (telephone) or 404-498-6535 (fax).

## Evaluation Guidelines

-   Each abstract will be reviewed by at least three reviewers according
    to the following six criteria: 1) significance to public health, 2)
    background and rationale for study, 3) appropriateness of
    methods, 4) presentation of results, 5) conclusions and
    interpretations of results, and 6) overall clarity of abstract.

-   Since some or all of the reviewers and those attending the
    conference may not be familiar with the subject matter, the author
    should explicitly address the public health significance of the
    subject and the rationale for the study. "Public health
    significance" refers to the magnitude of the health event, its
    seriousness, or its perceived importance to the public. The
    rationale should indicate why the study is being done (e.g., to
    answer a new question, to replicate a previous study to determine if
    the findings are replicable, or because of a public health need).

-   Abstracts will be considered as candidates for either oral or
    author-attended poster sessions. Once an abstract is accepted, the
    Scientific Program Committee will determine whether it is more
    appropriate for oral or poster presentation, on the basis of its
    complexity, need for graphic illustration, and other criteria (e.g.,
    whether or not more than one abstract by an author has been
    accepted, the themes chosen by the committee for oral and poster
    sessions, etc.). Assignment to an oral or poster session will be
    independent of the overall score given to the abstract in the
    selection process.

## Instructions for Abstract and Supporting Documentation Submission

-   Use Microsoft Word to create abstract. Save each abstract and other
    documents as separate files and use the following naming convention
    for each of the files:

  ------------------------------ ------------------- ---------------------
  **Document**                   **Naming            **Example**
                                 Convention**        

  Abstract                       Last name_abs.doc   Johnson_abs.doc

  Biographical Data Form (or CV) Last name_bio.doc   Johnson_bio.doc

  Conflict of Interest           Last name_disc.doc  Johnson_disc.doc
  Disclosure Form                                    

  Mackel Award Submission Form   Last name_mac.doc   Johnson_mac.doc

  Peavy Award Submission Form    Last Name_pea.doc   Johnson_pea.doc
  ------------------------------ ------------------- ---------------------

-   If you are submitting more than one abstract or other documents
    (e.g., two abstracts, Mackel Award forms, Peavy Award forms, and
    disclosure forms), use your last name, the appropriate characters,
    and a number to distinguish the various files (e.g.,
    johnson_abs1.doc, johnson_abs2.doc, johnson_mac1.doc,
    johnson_mac2.doc, johnson_pea1.doc, johnson_pea2.doc, etc.).

-   Abstracts may not exceed 275 words in length.

-   This word count includes the subheadings of the structured abstract
    (Background, Methods, Results, Conclusions) but does **not** include
    the title, author list, and information in the heading (the
    identification block), or key words. A word count is easily obtained
    by selecting the appropriate text of the abstract and then choosing
    the "Word Count" command in the "Tools" menu of Word.

-   Justification: left aligned only

-   Because of production limitations, no graphics can be accepted.

## Abstract Format (See sample abstract)

### 1. Identification Block: type the following, flush left, single-spaced

-   Presenter\'s/first author\'s name (last name, first name, middle
    initial), degrees, complete mailing address (CDC or other
    institution), and complete office telephone number. If the address
    is a CDC address, include center, division, branch, and mailstop.

-   EIS Class Year of Entry---20\_\_

-   Previous EIS Conference presentations, if any. Indicate year and
    type of presentation, e.g., oral, poster, and/or late-breaking
    report.

-   Mackel Award consideration: yes \_\_\_ no \_\_\_

    -   If yes, submit supporting information on attached form (Mackel
        Award Submission Form in Mackel2008.doc). Note that this
        supporting material should be submitted at the same time as the
        abstract itself and should be in a separate electronic file.

-   Peavy Award consideration: yes \_\_\_ no \_\_\_

    -   If yes, submit supporting information on attached form (Peavy
        Award Submission Form in Peavy2008.doc). Note that this
        supporting material should be submitted at the same time as the
        abstract itself and should be in a separate electronic file.

-   Willing to present at International Night: yes \_\_\_ no \_\_\_

-   Are there extenuating circumstances that would prevent you from
    presenting your paper in an oral session? yes \_\_\_ no \_\_\_

    -   If yes, please discuss with your Center's Scientific Program
        Committee representative.

-   Number of abstracts submitted: \_\_\_ If more than one, priority of
    this abstract: \_\_\_\_\_\_

    -   If you are submitting more than one abstract, please indicate
        the priority of each one (e.g., first, second, etc.)

### 2. Authors' names: type flush left.

-   First author (presenter). Type the full first name and middle
    initial, if any, before the last name (e.g., John H. Jones).

-   Co-authors. List each co-author in order of contribution by typing
    one initial followed by the last name (e.g., D. Smith, S. Brown).

### 3. Abstract title: type flush left. 

-   Be brief. Avoid subtitles if possible.

-   Capitalize major words only. Capitalize the second component of
    hyphenated terms.

-   Do NOT use abbreviations or acronyms in title.

-   Give geographic location (country, state or city) and dates of study
    or investigation. Do not abbreviate geographic locations; separate
    them from the rest of the title by an *em* dash with a space on
    either side of the *em* dash (e.g., "Outbreak of Pneumonia ---
    Texas, 1995")

### 4. Body of the abstract:

-   Double-space text in the body of the abstract.

-   Structure the abstract, using the following subheadings to identify
    each section: **Background**, **Methods**, **Results**,
    **Conclusions**.

-   Each subheading should be typed flush left, in bold font, and
    followed by a colon.

-   The **Background** section should address both 1) the public health
    significance of the subject and 2) the scientific background and
    rationale for the study (see sample abstract).

-   Since an abstract is a citable document, the **Results** section
    must contain data. It should not include such statements as \"Data
    will be discussed.\" ***If considerable work is needed before the
    conference, please state in the abstract that results are
    preliminary***.

-   Because of time constraints, changes cannot be made to the abstract
    after it is submitted to OWCD. You may find, however, that the
    results and conclusions of the study do change, based on data
    analysis done after submission of the abstract. If your abstract is
    accepted and significant changes have been made after submission of
    the abstract, please highlight the changes in your presentation,
    whether oral or poster.

### 5. Key words:

-   Please include 4--6 key words; use terms listed in the Medical
    Subject Headings (MeSH) from the Index Medicus
    (<http://www.nlm.nih.gov/mesh/meshhome.html>).

### 6. Word Count:

-   Abstracts are limited to a maximum of 275 words (see instructions
    above). If an abstract exceeds this length the review committee will
    either; a) deduct points from the final abstract score, b) truncate
    the abstract at 275 words, or c) reject the abstract outright.

## Style Guidelines

The *CDC Style Guide*, available at
<http://intranet.cdc.gov/od/dimes/guides/style/style.pdf>, is a helpful
reference tool.

-   Avoid the use of jargon, such as "cases" for "patients."

-   Always abbreviate CDC and ATSDR, but define all other abbreviations
    upon first use in the abstract, except for those used in standard
    measurements.\
    Example: "oral contraceptives (OC)" but "25 mg/L"

-   Use an *en* dash "--" with no spaces between characters to indicate
    ranges (e.g., \"2002--2005, "12%--20%").

-   Hyphenate time periods used as modifiers (e.g., "36-hour incubation
    period"), but do not hyphenate the following prefixes: anti, inter,
    intra, non, pre, and post.

-   *Etc.* has no place in scientific writing. Use *e.g.* and *i.e.*,
    which have different meanings, with care, and use them only within
    parentheses.

-   Spell out numbers less than 10 except in the case of standard units
    of measure such as time, dose, and temperature (e.g., \"two
    patients,\" but \"2 cc\" and \"9 p.m.\").

-   Use commas with numbers larger than 999 (e.g., "1,243 samples").

-   Use metric units. Show conventional terms, if desired, in
    parentheses.\
    Example: \"0^o^C (32^o^F).\"

-   Use standard \"mL,\" \"cm,\" etc. Exception: Use \"L\" for liter.

-   Use \"%\" with specific measurements (e.g., \"2%\"), but use
    \"percentage\" in stating a generality or category (e.g., \"The
    percentages reflect. . .\").

-   When a percentage is given in addition to a numerator and
    denominator, the percentage should directly follow the numerator and
    be enclosed in parentheses (e.g., \"18 (86%) of 21 patients\").

#   {#section .unnumbered}

# SAMPLE ABSTRACT

+-----------------------------------------------------------------------+
| Anderson, Mark A., MD, MPH, NCIPC, Division of Violence Prevention,   |
| Youth Violence Prevention Team, Mailstop K-60, 770/488--4762          |
|                                                                       |
| EIS Class Year of Entry: 1996                                         |
|                                                                       |
| One late-breaker presentation at 1997 EIS Conference                  |
|                                                                       |
| Mackel Award consideration: no                                        |
|                                                                       |
| Peavy Award consideration: yes                                        |
|                                                                       |
| Willing to present at International Night: yes                        |
|                                                                       |
| Number of abstracts submitted: 2 Priority of this abstract: 1^st^     |
|                                                                       |
| Mark A. Anderson, T. Simon, J. Sacks, A. Crosby                       |
|                                                                       |
| Suicidal Ideation Among Victims of Physical Assault --- United        |
| States, 1994                                                          |
|                                                                       |
| **Background:** Although interpersonal violence is a known risk       |
| factor for suicide, the relationship between specific characteristics |
| of violent assault and suicidal ideation, a predictor of suicide, are |
| not well understood. Understanding this relationship is important     |
| because there are an estimated 3.2 million victims of interpersonal   |
| violence and more than 30,000 suicides every year in the United       |
| States.                                                               |
|                                                                       |
| **Methods:** In a 1994 random-digit dialing telephone survey, 5,238   |
| adults were asked if they had considered suicide or been physically   |
| assaulted during the past 12 months. Logistic regression was used to  |
| generate adjusted odds ratios (AORs) for the association between      |
| suicidal ideation and physical assault. Among persons who had been    |
| assaulted, we modeled the number of victimizations, physical injury,  |
| and relationship with the perpetrator as predictors of suicidal       |
| ideation. All models included other risk factors for suicidal         |
| ideation such as sex, age, race, education, employment, marital       |
| status, and alcohol use as covariates.                                |
|                                                                       |
| **Results:** Overall, 5.6% of the respondents had considered suicide  |
| in the past 12 months. Among the 420 persons who had been physically  |
| assaulted, 21.5% had considered suicide, compared with 4.2% among     |
| nonvictims (AOR=3.5, 95% Confidence Interval \[CI\]=2.3--5.3). Within |
| the subgroup of victims, the likelihood of suicidal ideation was      |
| greatest among persons who were injured during the attack (AOR=2.8,   |
| 95% CI=1.3--6.2) or had been attacked by someone they knew (AOR=3.8,  |
| 95% CI=1.6--8.9), particularly an intimate partner (AOR=8.7, 95%      |
| CI=3.0--25.3).                                                        |
|                                                                       |
| **Conclusions:** Suicidal ideation may be a potential consequence of  |
| previous interpersonal violence victimization, particularly if the    |
| victim is injured or the perpetrator is an intimate partner of the    |
| victim. Providers caring for victims of interpersonal violence should |
| consider suicidal behavior as a possible sequela of assault.          |
|                                                                       |
| **Key words:** suicidal behavior, assault, violence, risk factor,     |
| victim                                                                |
|                                                                       |
| Are there extenuating circumstances that would prevent you from       |
| presenting your paper in an oral session? yes \_\_\_ no               |
| \_[X]{.underline}\_\_                                                 |
|                                                                       |
| Word Count: 273                                                       |
+-----------------------------------------------------------------------+

# EIS CONFERENCE ABSTRACT EVALUATION FORM

+-----------------------+---------------------------------+------------+
| **Scoring codes:**    | **Abstract number:**            |            |
|                       |                                 |            |
| 4 = Outstanding       |                                 |            |
|                       |                                 |            |
| 3 = Good              |                                 |            |
|                       |                                 |            |
| 2 = Fair              |                                 |            |
|                       |                                 |            |
| 1 = Poor              |                                 |            |
|                       |                                 |            |
| 0 = Unacceptable      |                                 |            |
+-----------------------+---------------------------------+------------+
|                       |                                 |            |
+-----------------------+---------------------------------+------------+
|                       |                                 |            |
+-----------------------+---------------------------------+------------+
|                       | **Total Score:**                |            |
+-----------------------+---------------------------------+------------+
|                       |                                 |            |
+-----------------------+---------------------------------+------------+
|                       |                                 |            |
+-----------------------+---------------------------------+------------+
|                       | ## Reviewer Number:             |      **    |
|                       |                                 | \--**      |
+-----------------------+---------------------------------+------------+

**EVALUATION CRITERIA COMMENTS (must comment for all scores \<1)**

  ------ -- ----------------------------------------------------------------
            A. Significance to public health

                 

            

            B. Background & rationale for study

                 

            

            C. Appropriateness of methods

                 

            

            D. Presentation of results

                 

            

            E. Conclusions & interpretations of results

                 

            

            F. Overall clarity of abstract

                 
  ------ -- ----------------------------------------------------------------

Additional Comments:

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

# BIOGRAPHICAL DATA FORM 57th Annual EIS Conference --- April 14--18, 2008

You may use this form or attach a current CV. This information is
required by accreditation organizations. It will be treated as a
confidential document.

  ---------------- ------------ ------ ------- --------- -------- ----------- ------- ---------- ---------
  Name/Degrees                                                    Date                                
                                                                  Submitted                      

                                                                                                 

  Business Address                                                                               

                                                                                                 

  Telephone                     Fax                      E-Mail                                  

                                                                                                 

  Position/Title                                                                                 
  ---------------- ------------ ------ ------- --------- -------- ----------- ------- ---------- ---------

**Education** (include basic preparation through highest degree held)

  -------------- -------------------------------- -----------------------
  Degree/Year    Institution, City, State         Major Area of Study

                                                       

                                                       

                                                       

                                                       

                                                       

                                                       

                                                       
  -------------- -------------------------------- -----------------------

**Professional Experience** (areas of expertise and publications
pertinent to this educational activity)

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

# DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS WITH COMMERCIAL INTERESTS Centers for Disease Control and Prevention Continuing Education 57th Annual EIS Conference --- April 14--18, 2008

  --------------------------- -------------------------------------------
  Name and Credentials             
  (Degrees)                   

                              

  Title, Center, Location          
  (EIS Officer)               
  --------------------------- -------------------------------------------

We are pleased that you are willing and able to participate in this
continuing education activity scheduled for April 14--18, 2008 in
Atlanta, GA .

The Centers for Disease Control and Prevention (CDC) is accredited by
multiple national accrediting organizations, and must meet their
requirements for accreditation. These organizations include the
Accreditation Council of Continuing Medical Education (ACCME), the
American Nurses Credentialing Center (ANCC),the International
Association for Continuing Education and Training (IACET), the National
Commission for Health Education Credentialing (NCHEC), the Accreditation
Council for Pharmacy Education (ACPE), and the American Association of
Veterinary State Boards/Registry of Approved Continuing Education
(AAVSB/RACE).

The Epidemic Intelligence Service (EIS) Conference is based on the
identified training needs of Epidemic Intelligence Service (EIS)
Officers. The primary purpose remains that of providing a training
experience of scientific presentations (oral or poster) for EIS
Officers, thus enabling EIS officers to satisfy one of the required Core
Activities for Learning (CAL) for successful completion of EIS.

**Your role for this activity is:** (Check all that apply):

Planner. My role is to maintain educational independence and/or
professional standards.

Presenter/Content Expert: The content will relate to

  ---------------------------------- ------------------------------------
  Title of presentation/talk/content      
  description                        

  ---------------------------------- ------------------------------------

[]{.mark}

CDC has implemented a process whereby all persons in positions of
control regarding the content of a continuing education (CE) activity
have disclosed all relevant financial relationships. The following are
definitions that pertain to this process:

1.  **"**Financial relationships" are relationships in which persons
    benefit by receiving a salary, royalty, intellectual property
    rights, consulting fees, honoraria, ownership interest (e.g.,
    stocks, stock options, or other ownership interest, excluding
    diversified mutual funds), or other financial benefits.

2.  Financial benefits are usually associated with roles (e.g.,
    employment, management position, independent contractor \[including
    contracted research\], consulting, speaking and teaching, membership
    on advisory committees or review panels, board membership, and other
    activities from which remuneration is received or expected). This
    condition is applicable to the person involved in the CE activity,
    as well as a spouse or partner with any commercial interest.

3.  "Commercial interest" is defined as any proprietary entity producing
    health-care goods or services, with the exemption of nonprofit or
    government organizations and nonhealth-care--related companies. If a
    conflict of interest exists as a result of a financial relationship
    you might have, this must be disclosed before the activity.

Please provide us with the following information by January 11, 2008.
This information is necessary to move to the next steps in planning this
activity. If you refuse to disclose relevant financial relationships,
which are defined as financial relationships in any amount occurring
within the past 12 months that create a conflict of interest, you will
be disqualified from being a part of the planning and implementation of
this CE activity. A conflict of interest is created when a person has an
opportunity to affect CE content concerning products or services of a
commercial interest with which he or she has a financial relationship.

4.  In the column labeled Commercial Interest, list the names of
    privately owned organizations producing health-care goods or
    services, with the exemption of nonprofit or government
    organizations and non-health-care--related companies with which you
    or your spouse or partner have, or have had, a relevant financial
    relationship within the past 12 months. For this purpose, we
    consider the relevant financial relationships of your spouse or
    partner that you are aware of to be yours.

5.  Without disclosing dollar amounts, describe what you or your spouse
    or partner received. Examples of what was received include salary,
    royalty, intellectual property rights, consulting fee, honoraria,
    stocks, ownership interest, or other financial benefits excluding
    diversified mutual funds.

6.  Describe your role with the commercial interest. Examples include
    employment, management position, independent contractor (including
    contracted research), consulting, speaking and teaching, membership
    on advisory committees or review panels, and board membership.

+--------------------+----------------------+--------------------------+
| Commercial         | Nature of Relevant   |                          |
| Interest           | Financial            |                          |
|                    | Relationship         |                          |
|                    |                      |                          |
|                    | (Include all that    |                          |
|                    | apply)               |                          |
+--------------------+----------------------+--------------------------+
|                    | What was received    | For what role?           |
+--------------------+----------------------+--------------------------+
| *Example: Company  | *Honorarium*         | *Speaker*                |
| 'X'*               |                      |                          |
+--------------------+----------------------+--------------------------+
|                    |                      |                          |
+--------------------+----------------------+--------------------------+
|                    |                      |                          |
+--------------------+----------------------+--------------------------+
|                    |                      |                          |
+--------------------+----------------------+--------------------------+
|                    |                      |                          |
+--------------------+----------------------+--------------------------+
|                    |                      |                          |
+--------------------+----------------------+--------------------------+

4\. I do not have any relevant financial relationships with any
commercial interests.

5a. Will your presentation(s) or the content you contribute include any
discussion of unlabeled use of commercial products or products for
investigational use?

YES NO NA (If Planner)

5b. If "yes," please explain your use of unlabeled products or products
under investigational use.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

6\. Is your presentation or the content you contribute supported by the
best available evidence-based medicine in a further effort to avoid
conflicts of interest?

YES NO NA (If Planner)

  ----------- ------------------------------------------------ ------ ---------
  Signature                                                    Date        

  ----------- ------------------------------------------------ ------ ---------

#  DONALD C. MACKEL MEMORIAL AWARD 57th Annual EIS Conference --- April 14--18, 2008

The EIS Alumni Association will sponsor the 23^rd^ Donald C. Mackel
Memorial Award, to be presented during the Conference. This award
recognizes the presentation that best exemplifies the effective
application of a combined epidemiological and laboratory approach to an
investigation. Presentations for which the first author is a current EIS
Officer and at least one coauthor is a laboratorian (CDC, state health
department, or other) may be considered for the award. The Mackel
Committee will NOT consider any abstract for the Mackel Award if
laboratory results are not included in the abstract.

The Donald C. Mackel Memorial Award Committee, co-chaired by
representatives from the Coordinating Center for Infectious Diseases and
the National Center for Environmental Health, will be responsible for
selecting the year 2008 winners.

## Instructions

If you wish to nominate your abstract for the Mackel Award, please do
the following:

1.  On the abstract, in the identification block, include the following:
    "Mackel Award consideration: yes."

```{=html}
<!-- -->
```
7.  Make sure that your abstract includes sufficient details about both
    epidemiological and laboratory studies so that the contribution of
    each component of the investigation and the degree of integration of
    the findings may be determined. NOTE: The Mackel Committee will NOT
    consider any abstract for which the laboratory results are not
    presented as a prominent part of the investigation.

8.  Complete the attached form, answering questions 1--5. You are not
    limited to one page.

9.  Submit completed Mackel Award Submission Form when you submit your
    EIS abstract.

# MACKEL AWARD SUBMISSION FORM

  -------------------- ---------------------------------------------------------
  Name                      

                       

  Title of abstract         

                       

  Name of laboratorian 
  who was principal    
  co-investigator      
  (Note: a single      
  laboratory scientist 
  must be designated   
  as principal         
  co-investigator.):   

                            
  -------------------- ---------------------------------------------------------

1\. What are the substantive laboratory components of this
investigation?

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

2\. What new or unique contributions did the laboratory make to this
investigation? Please describe in detail any new laboratory methods or
innovative uses of existing lab methods that were instrumental to the
success of this investigation (it is insufficient to state only that a
new protocol was developed).

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

3\. How did the laboratory co-authors contribute to this investigation?

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

4\. Please describe how the laboratory and epidemiological components of
the investigation complemented each other.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

5\. Please provide any additional comments you wish to make in support
of your abstract for the Mackel Award.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

# J. VIRGIL PEAVY MEMORIAL AWARD 57th Annual EIS Conference --- April 14--18, 2008

The EIS Alumni Association will sponsor the 6^th^ J. Virgil Peavy
Memorial Award, to be presented during the Conference. This award
recognizes the presentation that best exemplifies the effective
application of statistical methods to an investigation. Presentations
for which the first author is a current EIS Officer (CDC, state health
department, or other) may be considered for the award. The Peavy
Committee will NOT consider any abstract for the Peavy Award if
statistical methods, results, and interpretation are not included in the
abstract.

The J. Virgil Peavy Memorial Award Committee will be responsible for
selecting the year 2008 winners. 

## Instructions

If you wish to nominate your abstract for the Peavy Award, please do the
following:

1.  On the abstract, in the identification block, include the following:
    "Peavy Award consideration: yes."

```{=html}
<!-- -->
```
10. Make sure that your abstract includes sufficient details about
    statistical methods, results, and interpretation so that the
    contribution of each to the investigation may be determined. NOTE:
    The Peavy Committee will NOT consider any abstract for which the
    statistical methods, results, and interpretation are not presented
    as a prominent part of the investigation.

11. Complete attached form, answering questions 1--5. You are not
    limited to one page.

12. Submit completed Peavy Award Submission Form when you submit your
    EIS abstract.

# PEAVY AWARD SUBMISSION FORM

  ------------- ---------------------------------------------------------
  Name               

                

  Title of           
  abstract      
  ------------- ---------------------------------------------------------

1\. What are the substantive statistical components of this
investigation?

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

2\. What new or unique contributions did the statistical methods make to
solving or ameliorating this public health problem, not just for this
investigation, but which can be generalized?

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

3\. Please explain how the statistical results influenced your findings
and led to public health action.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

4\. Please describe how the statistical and epidemiological components
of the investigation complemented each other.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------

5\. Please provide any additional comments you wish to make in support
of your abstract for the Mackel Award.

  -----------------------------------------------------------------------
       

  -----------------------------------------------------------------------